Ilioinguinal Nerve Block in Transcatheter Aortic Valve Implantation

Does Ilioinguinal Block Provide Satisfactory Analgesia During Transcatheter Aortic Valve Implantation Procedure? A Comparative Study

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05220813

Enrollment

Registered

2022-02-02

Start date

2021-11-11

Completion date

2022-05-31

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

To assess the effect of iliohypogastric and ilioinguinal nerve block on the hemodynamic stability ,narcotic consumption and the rate of conversion to general anesthesia in patients undergoing transfemoral transcatheter aortic valve implantation (TF-TAVI).

Interventions

DRUGLidocaine

local infiltration by lidocaine in the surgical site

DRUGBupivacain

44patients will receive bupivacaine in ilioinguinal & iliohypogastric nerve blocks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* • Patients undergoing TF-TAVI. * Both sexes. * Age 18 and above

Exclusion criteria

* • Inability to tolerate supine position as in patients with musculoskeletal disease or back pain, OR in patients with congestive heart failure or with obstructive sleep apnea. * Patients with severe pulmonary hypertension (PAP\>60 mmhg) * Barrier to communications as language barrier or dementia. * Patients' preference of general anesthesia. * Surgical consideration as transapical, subclavian approach, extensive TEE requirements. * Patients with history of allergy to any drugs used. * Patients with psychiatric disease. * Patients with neurocognitive or neurodegenerative disease. * Secondary

Design outcomes

Primary

Measure	Time frame	Description
conversion to general anesthesia.	during the procedure (intraoperatively)	Conversion to general anesthesia in other than procedure related causes.

Secondary

Measure	Time frame	Description
propofol dose	during the procedure (intraoperatively)	Total dose of propofol per hour (0.025-0.075 mg /kg/min)
fentanyl dose	during the procedure (intraoperatively)	total dose of fentanyl 1-2 microgram / kg
sedation score	during the procedure (intraoperatively)	sedation score intraoperatively

Countries

Egypt

Contacts

Primary Contactismail M ibrahim, MD

doc_ismail_2006@yahoo.com+20224662448

Backup Contactmohamed mohsen mohamed, MD

00201204227780

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026